168 related articles for article (PubMed ID: 22434144)
1. Time-course of the change in titre of antibodies against type VII collagen in a patient with epidermolysis bullosa acquisita.
Sato M; Ishitsuka A; Shibuya Y; Kanoh H; Koga H; Hashimoto T; Seishima M
Acta Derm Venereol; 2012 Nov; 92(6):693-4. PubMed ID: 22434144
[No Abstract] [Full Text] [Related]
2. Familial epidermolysis bullosa acquisita.
Noe MH; Chen M; Woodley DT; Fairley JA
Dermatol Online J; 2008 Dec; 14(12):2. PubMed ID: 19265615
[TBL] [Abstract][Full Text] [Related]
3. Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita.
Ito Y; Kasai H; Yoshida T; Saleh MA; Amagai M; Yamagami J
J Dermatol; 2013 Nov; 40(11):864-8. PubMed ID: 24127822
[TBL] [Abstract][Full Text] [Related]
4. A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading.
Fairley JA; Woodley DT; Chen M; Giudice GJ; Lin MS
J Am Acad Dermatol; 2004 Jul; 51(1):118-22. PubMed ID: 15243536
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions.
Kim JH; Kim YH; Kim S; Noh EB; Kim SE; Vorobyev A; Schmidt E; Zillikens D; Kim SC
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e224-30. PubMed ID: 22731917
[TBL] [Abstract][Full Text] [Related]
6. Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies.
Nishida E; Nishio E; Murashima H; Ishii N; Hashimoto T; Morita A
J Dermatol; 2018 Apr; 45(4):472-474. PubMed ID: 29205468
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study.
Marzano AV; Cozzani E; Fanoni D; De Pità O; Vassallo C; Berti E; Parodi A; Crosti C; Cugno M
Br J Dermatol; 2013 Jan; 168(1):80-4. PubMed ID: 22913489
[TBL] [Abstract][Full Text] [Related]
8. Induction of experimental epidermolysis bullosa acquisita by immunization with murine collagen VII.
Sesarman A; Sitaru C
Methods Mol Biol; 2013; 961():371-87. PubMed ID: 23325658
[TBL] [Abstract][Full Text] [Related]
9. Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita.
Kasperkiewicz M; Hirose M; Recke A; Schmidt E; Zillikens D; Ludwig RJ
Br J Dermatol; 2010 May; 162(5):1064-70. PubMed ID: 20222918
[TBL] [Abstract][Full Text] [Related]
10. Epidermolysis bullosa acquisita: what's new?
Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
[TBL] [Abstract][Full Text] [Related]
11. Epidermolysis bullosa acquisita.
Gupta R; Woodley DT; Chen M
Clin Dermatol; 2012; 30(1):60-9. PubMed ID: 22137228
[TBL] [Abstract][Full Text] [Related]
12. The use of Biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita.
Marzano AV; Cozzani E; Biasin M; Russo I; Alaibac M
Arch Dermatol Res; 2016 May; 308(4):273-6. PubMed ID: 26895535
[TBL] [Abstract][Full Text] [Related]
13. T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita.
Sitaru AG; Sesarman A; Mihai S; Chiriac MT; Zillikens D; Hultman P; Solbach W; Sitaru C
J Immunol; 2010 Feb; 184(3):1596-603. PubMed ID: 20038644
[TBL] [Abstract][Full Text] [Related]
14. Management of epidermolysis bullosa acquisita.
Intong LR; Murrell DF
Dermatol Clin; 2011 Oct; 29(4):643-7. PubMed ID: 21925011
[TBL] [Abstract][Full Text] [Related]
15. Detection of anti-type VII collagen IgE antibodies in epidermolysis bullosa acquisita.
Koga H; Teye K; Yamashita K; Ishii N; Tsuruta D; Nakama T
Br J Dermatol; 2019 May; 180(5):1107-1113. PubMed ID: 30311191
[TBL] [Abstract][Full Text] [Related]
16. Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature.
Mayuzumi M; Akiyama M; Nishie W; Ukae S; Abe M; Sawamura D; Hashimoto T; Shimizu H
Br J Dermatol; 2006 Nov; 155(5):1048-52. PubMed ID: 17034540
[TBL] [Abstract][Full Text] [Related]
17. [Epidermolysis bullosa acquisita: literature review].
Le Roux-Villet C; Prost-Squarcioni C
Ann Dermatol Venereol; 2011 Mar; 138(3):228-46. PubMed ID: 21397153
[TBL] [Abstract][Full Text] [Related]
18. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA).
Seta V; Aucouturier F; Bonnefoy J; Le Roux-Villet C; Pendaries V; Alexandre M; Grootenboer-Mignot S; Heller M; Lièvre N; Laroche L; Caux F; Titeux M; Hovnanian A; Prost-Squarcioni C
J Am Acad Dermatol; 2016 Jun; 74(6):1166-72. PubMed ID: 26947449
[TBL] [Abstract][Full Text] [Related]
20. A case of epidermolysis bullosa acquisita with clinical features of Brunsting-Perry pemphigoid showing an excellent response to colchicine.
Tanaka N; Dainichi T; Ohyama B; Yasumoto S; Oono T; Iwatsuki K; Elfert S; Fritsch A; Bruckner-Tuderman L; Hashimoto T
J Am Acad Dermatol; 2009 Oct; 61(4):715-9. PubMed ID: 19679376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
